Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05232916 |
|---|---|
| Brief Title: | Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects (FLAMINGO-01) |
| First Submitted : | January 31, 2022 |
| First Submitted that Met QC Criteria : | January 31, 2022 |
| First Posted : | February 10, 2022 |
| Last Update Submitted that Met QC Criteria : | May 2, 2024 |
| Last Update Posted : | May 3, 2024 |